Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-23-005033
Filing Date
2023-07-06
Accepted
2023-07-06 08:27:57
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 12243
  Complete submission text file 0001477932-23-005033.txt   13800
Mailing Address 333 SOUTH GRAND AVENUE, 18TH FLOOR LOS ANGELES CA 90071
Business Address
GALLIGAN JOSEPH J (Reporting) CIK: 0001198613 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54208 | Film No.: 231072165

Mailing Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806
Business Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806 (714) 462-4880
BioCorRx Inc. (Issuer) CIK: 0001443863 (see all company filings)

EIN.: 900967447 | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC